David Peaper, MD
Pathology · New Haven, CTNPI 1932369295
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,225 of the $3,615 with a category attached, or 61.5%. Roche Diagnostics Corporation accounts for 61.5% of it on its own, with 2 other manufacturers making up the rest. Among pathology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 3 payments — averaging $1205.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$2K
- Gen-probe, Inc.$1K
- BD$390
Across 4 payments — averaging $35,707 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gen-probe, Inc.$143K
What the payments were for
- Consulting fees$1,39038%
- Speaking & faculty fees$2,22562%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 1 | $2,225 |
| Gen-probe, Inc. | 1 | $1,000 |
| BD | 1 | $390 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NONE$1,000
How this compares
$3,615 in reported general payments places this provider in the 95th percentile of 90 pathology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pathology in New Haven
- Sanja DacicNew Haven$128K
- Tore EidNew Haven$0
- Jennifer McNiffNew Haven$0
- Declan McGuoneNew Haven$0
- Kotaro TakedaNew Haven$0
- Nathan PaulsonNew Haven$0
- Po-Han ChenNew Haven$0
- Cameron BeechNew Haven$0
- Edward StitesNew Haven$0
- Joseph MisdrajiNew Haven$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.